Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-month, Prospective, Multicentre, Investigator-masked, Parallel-group, Active-controlled, Randomised, Non-inferiority Study to Compare the Efficacy & Tolerability of CATIONORM PRO® & VISMED® in Patients With Mod-to-severe Dry Eye Disease

NCT04701086 is registered in ClinicalTrials.gov with Santen SAS as lead sponsor.

NCT NCT04701086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-month, Prospective, Multicentre, Investigator-masked, Parallel-group, Active-controlled, Randomised, Non-inferiority Study to Compare the Efficacy & Tolerability of CATIONORM PRO® & VISMED® in Patients With Mod-to-severe Dry Eye Disease
Lead sponsor
Santen SAS
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2021
Completion date
April 28, 2025
Enrollment
83 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes